<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/2179308/open_sms">Send us a text</a>Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.

Send us a text Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.

<a href="https://www.buzzsprout.com/twilio/text_messages/2179308/open_sms" rel="noopener noreferrer">Send us a text</a>Matthew Zirwas, MD, discusses the efficacy, benefits, and safety profile of topical and systemic JAK inhibitors for the treatment of atopic dermatitis.&nbsp;

Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis

JCAD's audio platform provides interviews with leading experts in the dermatology field.&nbsp;

Medicine

Health & Fitness

JCAD's audio platform provides interviews with leading experts in the dermatology field. 

Share Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis

Sign up to save your podcasts

Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis

Matt Zirwas, MD: An Overview of Janus-kinase (JAK) inhibitors for Atopic Dermatitis

More shows like The Journal of Clinical and Aesthetic Dermatology

Emergency Medicine Cases

EADV Podcast

Derms on Drugs